Should modulation of p50 be a therapeutic target in the critically ill?

Amudan J. Srinivasan
, Clare Morkane
, Daniel S. Martin
, Ian J. Welsby^*

^*Corresponding author for this work

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	449-458
Number of pages	0
Journal	Expert Review of Hematology
Volume	10
Issue number	5
Early online date	12 Apr 2017
DOIs	https://doi.org/10.1080/17474086.2017.1313699
Publication status	Published - 4 May 2017

Access to Document

10.1080/17474086.2017.1313699

Cite this

@article{c739a010c8824034a16847b95f21f8a8,

title = "Should modulation of p50 be a therapeutic target in the critically ill?",

author = "Srinivasan, \{Amudan J.\} and Clare Morkane and Martin, \{Daniel S.\} and Welsby, \{Ian J.\}",

year = "2017",

month = may,

day = "4",

doi = "10.1080/17474086.2017.1313699",

language = "English",

volume = "10",

pages = "449--458",

journal = "Expert Review of Hematology",

issn = "1747-4086",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Should modulation of p50 be a therapeutic target in the critically ill?

AU - Srinivasan, Amudan J.

AU - Morkane, Clare

AU - Martin, Daniel S.

AU - Welsby, Ian J.

PY - 2017/5/4

Y1 - 2017/5/4

U2 - 10.1080/17474086.2017.1313699

DO - 10.1080/17474086.2017.1313699

M3 - Article

SN - 1747-4086

VL - 10

SP - 449

EP - 458

JO - Expert Review of Hematology

JF - Expert Review of Hematology

IS - 5

ER -